Credit where credit's due!
About time that management gave the market a little more guidance with the company's targets...
Frankly, the timing of the ending of this trial isn't too far away as well.
Print manufacturing by AML3D and testing, by Lightforce, is expected to be completed by Q3 FY22....so....1 Jan 2022 -> 31 March 2022
So only six to nine months away from a potential mega deal...
We'll start accumulating a position on weakness.
- Forums
- ASX - By Stock
- Ann: Prototype testing of next-gen body armour expanded
AL3
aml3d limited
Add to My Watchlist
2.08%
!
24.5¢

Credit where credit's due! About time that management gave the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $129.0M |
Open | High | Low | Value | Volume |
28.0¢ | 28.5¢ | 24.0¢ | $2.016M | 7.732M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 320622 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 135499 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 369891 | 0.245 |
19 | 415539 | 0.240 |
11 | 139446 | 0.235 |
11 | 223218 | 0.230 |
5 | 85500 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 135499 | 2 |
0.255 | 195482 | 5 |
0.260 | 288124 | 9 |
0.265 | 446230 | 8 |
0.270 | 276115 | 3 |
Last trade - 10.41am 07/07/2025 (20 minute delay) ? |
Featured News
AL3 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online